Prosecution Insights
Last updated: April 19, 2026

Ads Therapeutics LLC

4 pending office actions

Portfolio Summary

4
Total Pending OAs
2
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18034710 OCULAR ANTIBODY-DRUG CONJUGATES AEDER, SEAN E 1642 Non-Final OA Apr 30, 2023
18029323 TOPICAL OPHTHALMOLOGICAL COMPOSITIONS CHANDRAKUMAR, NIZAL S 1625 Non-Final OA Mar 29, 2023
17927796 TOPICAL OPHTHALMOLOGICAL COMPOSITIONS AND METHODS FOR TREATING ABNORMAL ANGIOGENESIS FAY, ZOHREH ALEMZADEH 1617 Final Rejection Nov 25, 2022
17624516 COMPOSITIONS AND METHODS FOR TREATING EYE DISEASES BAKSHI, PANCHAM 1623 Final Rejection Jan 03, 2022

Managing Ads Therapeutics LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month